newsfilter
← Latest News
GlobeNewswire·

Vericel to Present at the 24th Annual Morgan Stanley Global Healthcare Conference on Tuesday, September 15, 2026

  • Vericel Corporation (NASDAQ: VCEL) will present at the 24th Annual Morgan Stanley Global Healthcare Conference on Tuesday, September 15, 2026.
  • A webcast of the presentation will be available on the Investor Relations section of the Vericel website at investors.vcel.com.
  • The Company operates as a leader in advanced therapies for the sports medicine & severe burn care markets.
  • Vericel markets three products in the United States: MACI for repairing full-thickness cartilage defects of the knee; Epicel for permanent skin replacement for deep dermal or full-thickness burns greater than or equal to 30% of total body surface area; & NexoBrid, for which Vericel holds exclusive North American rights to remove eschar in adults & pediatric patients with thermal burns.
  • Investor inquiries can be directed to Eric Burns at ir@vcel.com or +1 (734) 418-4411.